Job Search EngineJob Openings with Novartis Pharmaceuticals
Official Novartis Pharmaceuticals Tweets for @novartis
- #woc12: AMD is a degenerative eye disease that is a leading cause of severe vision loss in people over 50 in the Western world (3:00am on Mon, February 13)
- For 740 million people in India, access to healthcare is an issue. http://t.co/V9w1UJcg #ArogyaParivar helps deliver healthcare to those... (10:30am on Sat, February 11)
- Dr. Shah discusses how #Novartis provides treatments & funds rehabilitation projects for India’s leprosy patients http://t.co/bMajLhQd (5:06pm on Fri, February 10)
- #DidYouKnow: Most #breastcancer patients who respond to initial hormonal therapy develop resistance (1:00pm on Fri, February 10)
- Novartis continues to research ways to control tumor growth in advanced #breastcancer (9:00am on Fri, February 10)
- Dr. Shah discusses how #Novartis provides needed treatments & funds rehabilitation projects for India’s leprosy patients... (8:30am on Fri, February 10)
- In advanced #breastcancer tumors develop in parts of the body beyond the breast and lymph nodes (4:00pm on Thu, February 9)
- Phase III BOLERO-2 study in advanced #breastcancer published in today’s NEJM http://t.co/GACtNLQ2 (2:00pm on Thu, February 9)
- #DidYouKnow: Every year approx. 220,000 women globally will be diagnosed with ER+HER2- advanced #breastcancer (12:00pm on Thu, February 9)
- In India, self-care kits help leprosy patients address their wounds and take their healthcare into their own hands http://t.co/8ninB2Gh (11:54am on Thu, February 9)
Recent on Google News
Alnylam Delivers In-Line Numbers
Zacks.com
... $5.5 million from Alnylam's partnership with Takeda Pharmaceuticals, in addition to $1.0 million of expense reimbursement, amortization revenues and license fees from Cubist Pharmaceuticals (CBST), Novartis (NVS) and other sources.
Alnylam Pharmaceuticals Announces Proposed Public Offering of Common StockMarketWatch (press release)
all 14 news articles »
Zacks.com
... $5.5 million from Alnylam's partnership with Takeda Pharmaceuticals, in addition to $1.0 million of expense reimbursement, amortization revenues and license fees from Cubist Pharmaceuticals (CBST), Novartis (NVS) and other sources.
Alnylam Pharmaceuticals Announces Proposed Public Offering of Common StockMarketWatch (press release)
all 14 news articles »
Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens ...
MarketWatch (press release)
He has been in the pharmaceutical industry for 22 years, having held significant leadership roles at Novartis and Merck. Mr. Ernst serves as vice president of quality at the Rocky Mount plant, where he is accountable for all site quality as well as ...
and more »
MarketWatch (press release)
He has been in the pharmaceutical industry for 22 years, having held significant leadership roles at Novartis and Merck. Mr. Ernst serves as vice president of quality at the Rocky Mount plant, where he is accountable for all site quality as well as ...
and more »
KSDK
Novartis Settles US Overtime Case
Wall Street Journal
By CHAD BRAY A Novartis AG US subsidiary agreed to pay $99 million to settle long-running overtime litigation involving its sale representatives. A group of current and former sales representatives sued Novartis Pharmaceuticals Corp. in 2006, ...
Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation ...MarketWatch (press release)
Novartis to pay $99 million to settle federal lawsuit over sales ...Washington Post
all 102 news articles »
Wall Street Journal
By CHAD BRAY A Novartis AG US subsidiary agreed to pay $99 million to settle long-running overtime litigation involving its sale representatives. A group of current and former sales representatives sued Novartis Pharmaceuticals Corp. in 2006, ...
Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation ...MarketWatch (press release)
Novartis to pay $99 million to settle federal lawsuit over sales ...Washington Post
all 102 news articles »
FDA wants more info on Menveo; advisory negative on Dacogen
The Pharma Letter
Novartis submitted the supplemental Biologics License Application for Menveo to the FDA in April 2011, following a Refuse to File letter from the agency for use of the vaccine in infants (The Pharma Letter January 31, 2011). The news Complete Response ...
FDA requests additional data on Novartis quadrivalent meningococcal conjugate ...Reuters
all 23 news articles »
The Pharma Letter
Novartis submitted the supplemental Biologics License Application for Menveo to the FDA in April 2011, following a Refuse to File letter from the agency for use of the vaccine in infants (The Pharma Letter January 31, 2011). The news Complete Response ...
FDA requests additional data on Novartis quadrivalent meningococcal conjugate ...Reuters
all 23 news articles »
LEO Pharma sued over wage-and-hour violations
Business Insurance
... plaintiffs law firm Sanford Wittels & Heisler LLP, which last month reached a $99 million settlement in a wage-and-hour class action lawsuit filed against another pharmaceuticals firm, East Hanover, NJ-based Novartis Pharmaceuticals Corp.
Leo Pharma Sales Reps File Overtime Class Action in New York Federal CourtMarketWatch (press release)
all 6 news articles »
Business Insurance
... plaintiffs law firm Sanford Wittels & Heisler LLP, which last month reached a $99 million settlement in a wage-and-hour class action lawsuit filed against another pharmaceuticals firm, East Hanover, NJ-based Novartis Pharmaceuticals Corp.
Leo Pharma Sales Reps File Overtime Class Action in New York Federal CourtMarketWatch (press release)
all 6 news articles »
Drug company pays $99M to settle wage dispute
Opelika Auburn News
This has been one of the most highly watched FLSA cases in the last five years for the pharmaceutical industry. The proposed settlement agreement covers five subclasses of Novartis sales representatives who allege they were denied overtime pay in ...
and more »
Opelika Auburn News
This has been one of the most highly watched FLSA cases in the last five years for the pharmaceutical industry. The proposed settlement agreement covers five subclasses of Novartis sales representatives who allege they were denied overtime pay in ...
and more »
«Market Leader» - news and previews making you rich.
Recommendations to Investors: Celgene Corp.
«Market Leader» - news and previews making you rich.
Additional revenues are generated by sales of FOCALIN for Novartis Pharma AG (Novartis). On 15 January 2010 CELG acquired Gloucester Pharmaceuticals, Inc (Gloucester), a private pharmaceutical company. On 15 October 2010 the company acquired Abraxis ...
Morgan Stanley Analysts Now Covering Celgene Stock (CELG)Web Inquirer
all 3 news articles »
«Market Leader» - news and previews making you rich.
Additional revenues are generated by sales of FOCALIN for Novartis Pharma AG (Novartis). On 15 January 2010 CELG acquired Gloucester Pharmaceuticals, Inc (Gloucester), a private pharmaceutical company. On 15 October 2010 the company acquired Abraxis ...
Morgan Stanley Analysts Now Covering Celgene Stock (CELG)Web Inquirer
all 3 news articles »
After dropping ISTA, Valeant nabs another eye-drug company
FiercePharma
So what if Valeant Pharmaceuticals wasn't able to pull off its bid for ISTA Pharmaceuticals? It's snapping up Eyetech instead. The Canadian drugmaker ($VRX) agreed to pay "significantly less than two times sales" for Eyetech, which markets Macugen, ...
and more »
FiercePharma
So what if Valeant Pharmaceuticals wasn't able to pull off its bid for ISTA Pharmaceuticals? It's snapping up Eyetech instead. The Canadian drugmaker ($VRX) agreed to pay "significantly less than two times sales" for Eyetech, which markets Macugen, ...
and more »
Unigene Announces Key Appointments as Biotechnologies Strategic Business Unit ...
MarketWatch (press release)
- Gregory T. Mayes, Esq. Promoted to Chief Business Officer - - Jane Pepper, MBA, Ph.D., Formerly of Novartis Pharmaceuticals, Appointed to Senior Director, Business Development - BOONTON, NJ, Feb. 8, 2012 /PRNewswire via COMTEX/ -- Unigene ...
and more »
MarketWatch (press release)
- Gregory T. Mayes, Esq. Promoted to Chief Business Officer - - Jane Pepper, MBA, Ph.D., Formerly of Novartis Pharmaceuticals, Appointed to Senior Director, Business Development - BOONTON, NJ, Feb. 8, 2012 /PRNewswire via COMTEX/ -- Unigene ...
and more »
Mass High Tech
Alnylam to speed lead drug candidates' development
Mass High Tech
By Lori Valigra Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) of Cambridge said it will accelerate development of two lead drug candidates that offer the greatest commercial opportunity, and that it has discovered a novel method to monitor the activity ...
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial ...MarketWatch (press release)
Alnylam Scientists Discover Novel Method for Monitoring RNAi Activity in Blood ...EON: Enhanced Online News (press release)
Alnylam To Webcast Presentations At Upcoming Investor ConferencesTheStreet.com (press release)
all 34 news articles »
Mass High Tech
By Lori Valigra Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) of Cambridge said it will accelerate development of two lead drug candidates that offer the greatest commercial opportunity, and that it has discovered a novel method to monitor the activity ...
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial ...MarketWatch (press release)
Alnylam Scientists Discover Novel Method for Monitoring RNAi Activity in Blood ...EON: Enhanced Online News (press release)
Alnylam To Webcast Presentations At Upcoming Investor ConferencesTheStreet.com (press release)
all 34 news articles »
Novartis Pharmaceuticals Location
Phone: 1-800-277-2254
New York,NY 10020
Work for Novartis Pharmaceuticals and want to make adjustments to this page? Contact us to be given access to our management tools.
Searches of the following companies will also return job listings at Novartis Pharmaceuticals:
- Chiron Corp
Cities with the Most Jobs
Cities with Recent Job Growth
States with Recent Job Growth
Most Popular Job Titles
Fastest Growing Job Titles
- Associate Manager- I
- Bi-lingual Inventory Analyst
- Bioanalytics Laboratory Manager
- Compliance Assistant (half-time)
- Head Medical Affairs (f/m)
- Manufacturing Line Leader
- Ra Labelling Senior Specialist
- Regional Medical Affairs Clinical Operations Manager-egm
- Safety Mgmt Team Coordinator
- Senior Product Manager (high-tech Products)